tm logo

Monitor this mark

View On USPTO

COLORADO HEALTH & TECH CENTERS
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 07 Feb 2024

Last Applicant/ Owned by

Safavi Applied Life Sciences, LLC

PO Box 244

Breckenridge

CO

80424

Serial Number

97554743 filed on 18th Aug 2022

Registration Number

N/A

Correspondent Address

James Hubbard

James Hubbard

7373 S Alton Way, Ste. 100, Ste. 100

7373 S Alton Way, Ste. 100

Centennial,CO 80112

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

COLORADO HEALTH & TECH CENTERS

Real estate consultation; Real estate management Real estate development

Classification Information

Class [037]
Construction and Repair Services

Real estate development

First Use Date in General

04th Aug 2022

First Use Date in Commerce

04th Aug 2022

Class [036]
Insurance & Financial Services

Real estate consultation; Real estate management

First Use Date in General

04th Aug 2022

First Use Date in Commerce

04th Aug 2022

Specimens

COLORADO HEALTH & TECH CENTERS specimenCOLORADO HEALTH & TECH CENTERS specimenCOLORADO HEALTH & TECH CENTERS specimenCOLORADO HEALTH & TECH CENTERS specimenCOLORADO HEALTH & TECH CENTERS specimenCOLORADO HEALTH & TECH CENTERS specimen

Mark Details

Serial Number

No 97554743

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
07th Feb 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
07th Feb 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
24th Oct 2023FINAL REFUSAL WRITTEN
24th Oct 2023FINAL REFUSAL E-MAILED
24th Oct 2023NOTIFICATION OF FINAL REFUSAL EMAILED
16th Sep 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16th Sep 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th Sep 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th Sep 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
16th Sep 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED